The Patent Finder

Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases

Prime Merger Sub, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 62/140,909, filed Mar 31, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,433,918Methods of Treating Joint Disease, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinase
In force
 · High confidence
Prime Merger Sub, LLCIn force
High confidence
US 10,576,107Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases
In force
 · High confidence
Prime Merger Sub, LLCIn force
High confidence
US 11,666,606Methods of Treating Joint Disease, Disorders and Conditions with Tissue Inhibitors of Matrix Metalloproteinases
In force
 · Low confidence
Prime Merger Sub, LLCIn force
Low confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited